InvestorsHub Logo
icon url

Doktornolittle

01/14/17 12:04 PM

#95629 RE: Doktornolittle #95626

But one could argue that it is a different indication, being recurrent GBM rather than new GBM. That is the question... would that be enough of a difference in indications for the FDA to ignore a futility finding for the first?